Jia Pang

发表

Genomic and Transcriptomic Features of Response to Anti-PD-1 Therapy in Metastatic Melanoma

J. Sosman, A. Ribas, Douglas B. Johnson, 2016, Cell.

Mutations Associated with Acquired Resistance to PD-1 Blockade in Melanoma.

T. Graeber, T. Schumacher, B. Comin-Anduix, 2016, The New England journal of medicine.

Erratum: Genomic and Transcriptomic Features of Response to Anti-PD-1 Therapy in Metastatic Melanoma (Cell (2016) 165(1) (35–44)(S009286741630215X)(10.1016/j.cell.2016.02.065))

J. Sosman, A. Ribas, Douglas B. Johnson, 2017 .

A Phase I, Open-label, Dose-escalation, and Cohort Expansion Study to Evaluate the Safety and Immune Response to Autologous Dendritic Cells Transduced With AdGMCA9 (DC-AdGMCAIX) in Patients With Metastatic Renal Cell Carcinoma

A. Belldegrun, B. Comin-Anduix, A. Pantuck, 2020, Journal of immunotherapy.

IND-Enabling Studies for a Clinical Trial to Genetically Program a Persistent Cancer-Targeted Immune System

K. Cornetta, D. Baltimore, A. Ribas, 2018, Clinical Cancer Research.

Human Papillomavirus Species-Specific Interaction with the Basement Membrane-Resident Non-Heparan Sulfate Receptor

M. Sapp, S. Mukherjee, M. Bienkowska-Haba, 2014, Viruses.

The antitumor activity of the fungicide ciclopirox

Xiuzhen Han, Lei Liu, Jia Pang, 2010, International journal of cancer.

A Pilot Trial of the Combination of Transgenic NY-ESO-1–reactive Adoptive Cellular Therapy with Dendritic Cell Vaccination with or without Ipilimumab

B. Comin-Anduix, A. Ribas, A. Cochran, 2018, Clinical Cancer Research.

Genomic and Transcriptomic Features of Response to Anti-PD-1 Therapy in Metastatic Melanoma

J. Sosman, A. Ribas, Douglas B. Johnson, 2017, Cell.